SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (37)3/2/1999 12:44:00 PM
From: celeryroot.com  Read Replies (1) | Respond to of 555
 
" Yes, since the "crash" (cancellation of agreement) as a matter of fact."
exchange2000.com
This is false, there was no cancellation of agreement

"Eli Lilly informed LGND that they will not proceed with their agreement to develope oral Targretin and the two
other first generation compounds in the RXR program sending the stock "crashing"."
exchange2000.com
This is false

Anyone can check open interest at numerous sites WWW.cboe.com for one. Ligand March open net has changed very little since early Feb